Academic studies forthcoming:
|PREV'HOSPIT||PHRC-N||Amandine GAGNEUX et Elisabeth BOTELHO – NEVER||Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine administered during a systemic inflammatory response syndrome: a multicentre randomized study.|
|PHRC-N||Odile LAUNAY et Muhamed kheir TAHA||Multicenter, randomized phase 2 trial, evaluating the immunogenicity and tolerance of three vaccine strategies against Meningococcus B in splenectomized patients.|
|PHRC-N||Paul LOUBET et Odile Launay||Vaccine attitudes and practices of medical specialists in hospitals|
Academic studies on going:
|Odile Launay||Cochin, Bichat, Montpellier, Lyon et Rennes||Evaluation of the vaccine efficacy of the influenza vaccine in hospitalized adults|
Network centers: Annecy,ClermontFerrand, Cochin, Dijon, Lille, Nîmes, Rennes,Roche-sur-Yon and Strasbourg.
Angers, Hôpital Avicenne, Bordeaux, Brest, Créteil, Grenoble, HEGP, Metz, Nirot, Hôpital Tenon,Toulouse, Tours and Valencienne.
Test carried out with the IMMIDIATE network.
|Multicentric trial comparing the immunogenicity and safety of two innovative pneumococcal vaccine strategies to standard vaccination in patients with ANCA-associated vasculitis receiving rituximab|
Centers of the Network : Annecy, Cochin, Lille, Lyon, Rennes et Saint-Etienne.
|Evaluation of the efficacy of tetravalent HPV vaccine on the secondary prevention of reccurence of external a no genital warts in clinically cured patients in the first place|
|SPLENEVAC 2||PHRC-N||Odile LAUNAY et Benjamin ROSSI||
14 centers are participating in the study, including 11 network centers:
Annecy, Besançon, Bichat Cochin, Dijon, Lille, Nantes, Rennes and St-Etienne.
Clermont-Ferrand and Montpellier.
|Evaluation of the immunological persistence of revaccination with the PPS23 vaccine boosted or not by PCV 13 in splenectomized patients|
18 centers participate, including 12 from the network
|Prospective randomized trial evaluating the effectiveness of BCG vaccination in the prevention of COVID 19 via the strengthening of innate immunity in healthcare personnel|